Recently published

Jurisdiction / Region

  • Loading...

More information




CMS Worldwide

Selected jurisdiction


Latest news

Press contact





404 - Page not found

404 - Page not found

Unfortunately, we can’t seem to find the page you’re looking for.

Error code: 404



Next Events


CMS on LinkedIn

Follow us

Picture of Vera Zhang

Vera Zhang

Senior Associate

Languages Chinese, English

Vera is specialising in venture capital and private equity investment, cross-border M&A transactions, IPOs, bond issuance and capital market transactions. Vera advises clients in reorganisation, due diligence, the reviewing and drafting of legal documents, as well as conducting legal research on various aspects of the People’s Republic of China (PRC) laws and policies.

Before joining CMS, Vera worked for several top-tier law firms in the PRC where she was involved in various international IPOs in different industries such as real estate, consumer products, manufacturing, TMC and lifesciences. She has also been involved in venture capital and private equity investments for international funds, local funds and investment companies, as well as developing companies.

more less


  • LL.B degree and LL.M degree on International Economic Law from the University of International Business and Economics
more less



Show only
De­liv­er­ing Con­sumer Products ex­pert­ise in China
China’s NDRC seeks pub­lic com­ments on im­port­ant out­bound in­vest­ment...
On 3 Novem­ber 2017, the Na­tion­al De­vel­op­ment and Re­form Com­mis­sion (“NDRC”), one of China’s key out­bound in­vest­ment reg­u­lat­ory bod­ies, has is­sued the An­nounce­ment on Seek­ing Pub­lic Com­ments on the Ad­min­is­trat­ive Meas­ures for Out­bound In­vest­ment of En­ter­prises.
MOF­COM amends the In­ter­im Ad­min­is­trat­ive Meas­ures for the Re­cord-fil­ing...
On 30 Ju­ly 2017, the Min­istry of Com­merce (the “MOF­COM”) an­nounced a de­cision to amend (the "Amend­ment De­cision”), the In­ter­im Ad­min­is­trat­ive Meas­ures for the Re­cord-fil­ing of the In­cor­por­a­tion and Change of For­eign-in­ves­ted En­ter­prises (the “Meas­ures”).
Sev­en new Free Trade Zones have opened in China
An of­fi­cial state­ment re­leased on 31 March 2017 an­nounced that the State Coun­cil had ap­proved sev­en new Free Trade Zones (“FTZs”) in the provinces of Liaon­ing, Zheji­ang, Hen­an, Hubei, Sichuan, Shaanxi and Chongqing Mu­ni­cip­al­ity.
After 30 years China over­hauls its civil law
Fol­low­ing the ex­am­in­a­tion of three draft ver­sions of the Gen­er­al Rules of the Civil Law of the People’s Re­pub­lic of China (“the Rules”), the fi­nal ver­sion of the Rules has been ad­op­ted at the Fifth Ses­sion of the 12th Na­tion­al People's Con­gress of the People's.
China opens up ci­vil­ian air­port mar­ket to private in­vestors
Re­cently, the Civil Avi­ation Ad­min­is­tra­tion of China (“CAAC”), the reg­u­lat­ory au­thor­ity in charge of the avi­ation sec­tor, is­sued the Opin­ion on the En­cour­age­ment of So­cial Cap­it­al In­vest­ment in the Con­struc­tion and Op­er­a­tion of Civil Air­port (the “Opin­ion”).
Tetra Pak fined EUR 91 mil­lion for ab­use of dom­in­ant po­s­i­tion in China
The State Ad­min­is­tra­tion for In­dustry and Com­merce (“SAIC”), the reg­u­lat­ory au­thor­ity in charge of en­force­ment against non-price re­lated mono­poly activ­it­ies, has an­nounced last week its de­cision to fine Swedish pack­aging com­pany, Tetra Pak In­ter­na­tion­al S.
China to tight­en veri­fic­a­tion pro­cess to stop fake over­seas M&A deals
The State Ad­min­is­tra­tion of For­eign Ex­change (the “SAFE”), the main au­thor­ity in charge of for­eign ex­change con­trol in China, an­nounced last week that they will crack down on fake over­seas M&A deals in or­der to curb cap­it­al flight.
China to set up sev­en new Free Trade Zones
The Min­is­ter of Com­merce for China has an­nounced the set-up of sev­en new Free Trade Zones (“FTZs”) in Liaon­ing, Zheji­ang, Hen­an, Hubei, Sichuan, Shanxi province and Chongqing city. China set-up its first FTZ in Shang­hai in 2013, which was fol­lowed a year.
NDRC launches anti-trust in­vest­ig­a­tion in­to phar­ma­ceut­ic­al sec­tor
China’s top pri­cing-re­lated anti-trust reg­u­lat­or, the Na­tion­al De­vel­op­ment and Re­form Com­mis­sion (“NDRC”), has launched a new round of anti-trust in­vest­ig­a­tions in­to phar­ma­ceut­ic­al com­pan­ies. A ma­jor US phar­ma­ceut­ic­al com­pany has been summoned for in­quiry and.